ライフサイエンスコーパス: ethyl

1 cent dye trans-2-[4-(dimethylamino)styryl]-3-ethyl-1,3-benzothiazolium perchlorate (DMASEBT) is a rel

2 With untargeted metabolomic approaches, 2-ethyl-1-hexanol could potentially be applied as an aroma

3 ree compounds: ethanol, 2,3-butanediol and 2-ethyl-1-hexanol were selected based on the loading plot

4 ptotic inducer, topoisomerase I inhibitor, 7-ethyl-10-hydrocamptothecin (SN38) on human colorectal ca

5 l, irinotecan and its important metabolite 7-ethyl-10-hydroxycamptothecin, and certain tyrosine kinas

6 s been developed from commercially available ethyl [(13) C(4) ]-acetoacetate ([(13) C(4) ]-15).

7 Herbicides included fenoxaprop-p-ethyl (140 g ha(-1)), topramezone (25 g ha(-1)), foramsu

8 strol, camptothecin, IP7e, isoalantolactone, ethyl 2-[2,3,4-trimethoxy-6-(1-octanoyl)phenyl]acetate (

9 ion, enantioselective indole alkylation with ethyl 2-diazopropanoate, and cyclic internal alkene cycl

10 ween N, N'-dicyclohexylbarbituric acid 1 and ethyl 2-isocyanatoacetate 2 is invariant with temperatur

11 In the oaky model, a vector containing just ethyl 2-methylbutyrate (V7) could replace V1 without any

12 aced by a vector containing just 3 odorants (ethyl 2-methylbutyrate, ethyl butyrate and hexanoate).

13 de, 2-phenylethanol, methionol, capric acid, ethyl 2-methylbutyrate, ethyl isovalerate, ethyl monosuc

14 novel c-Myc-targeting compound, N, N-bis (5-ethyl-2-hydroxybenzyl) methylamine (EMD), and present ev

15 ed the effect of a new compound, N, N-bis (5-ethyl-2-hydroxybenzyl) methylamine (EMD), in targeting c

16 ent scavenger of dicarbonyl electrophiles, 5-ethyl-2-hydroxybenzylamine (EtHOBA), was determined in t

17 xy-5H-1,4b,9-triaza(indeno[2,1-a]inden-10-yl)ethyl]-2-furamide (S29434 or NMDPEF; IC(50) = 5-16 nM) o

18 m concentration recommended by Cramer, e.g., ethyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate a

19 Methyl and ethyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate w

20 o-N-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-3-(4-hydroxyphenyl)acrylamide (CHC-Mal), for sele

21 The highest FD factor (2048) was found for 2-ethyl-3,5-dimethylpyrazine and 2-ethyl-3-methyl pyrazine

22 d a modified protein-conjugating compound, 1-ethyl-3-(3'dimethylaminopropyl)-carbodiimide (ECDI), to

23 with anti-RGS11 antibodies (Ab-MB) by EDC (1-ethyl-3-(3-(dimethylamino)propyl)-carbodiimide)/NHS ( N-

24 to footprint carboxylic residues, whereby 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide activates

25 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N

26 n be prevented by additional fixation with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) for v

27 as nontoxic cross linker and activated by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochlori

28 surface modified with N-hydroxysuccinimide/1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide) (NHS/EDC)-

29 via carbodiimide activation chemistry with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)/N-hydr

30 orm consisting of acetylene-functionalized 3-ethyl-3-(hydroxymethyl)oxetane (EAMO) repeat units (Pate

31 er 24 h incubation with HPPH [3-(1'-hexyloxy)ethyl-3-devinyl-pyropheophorbide-a) by ultrasound partic

32 found for 2-ethyl-3,5-dimethylpyrazine and 2-ethyl-3-methyl pyrazine in the MRC and DRC brew samples,

33 ionic-liquid (IL) electrolyte composed of 1-ethyl-3-methylimidazolium (EMIm) cations and high-concen

34 The two best ILs, choline hexanoate and 1-ethyl-3-methylimidazolium acetate, were compared with th

35 nt additives, ethylaluminum dichloride and 1-ethyl-3-methylimidazolium bis(fluorosulfonyl)imide.

36 carbon paste electrode (CPE) modified with 1-ethyl-3-methylimidazolium chloride as an ionic liquid (I

37 a signaling element, and the ionic liquid (1-ethyl-3-methylimidazolium dicyanamide) provides the requ

38 The ionic liquid 1-ethyl-3-methylimidazolium methanesulfonate ([EMIM][MeSO(

39 he FIL/IL that revealed the best behavior, 1-ethyl-3-methylimidazolium triflate.

40 -co-HFP, a gelling agent, and ionic liquid 1-Ethyl-3-methylimidazolium trifluoromethanesulfonate, EMI

41 nition began with the synthesis of (2S,3S)-2-ethyl-3-methylpent-4-ynoic acid, a precursor to the tran

42 ury, its pharmacological activation by 6beta-ethyl-3a,7b-dihydroxy-5b-cholan-24-ol rescues mice from

43 plus other risk factors to receive icosapent ethyl 4 g/d or placebo.

44 osclerosis or diabetes mellitus to icosapent ethyl 4 g/d or placebo.

45 nts) or diabetes (29% patients) to icosapent ethyl 4 g/day or placebo.

46 generate NADH to support the conversion from ethyl 4-chloroacetoacetate (COBE) to ethyl (S)-4-chloro-

47 o-1-(3',4',5'-trifluoro-[1,1'-biphenyl]-4-yl)ethyl)-4-(methylsulfonamido)benzamide (6ad) proved to be

48 ound for this study ((3-(N-butylethanimidoyl)ethyl)-4-hydroxy-2H-chromen-2-one; BHC) was previously d

49 )-2-methoxy-4-(1-(2-(1-methylpyrrolidin-2-yl)ethyl)-4-phenyl-1H-imidazol-5-yl)phenol (H23), as a firs

50 iency and the concentration of generated (R)-ethyl-4-cyano-3-hydroxybutyrate ((R)-CHCN).

51 s to the [4Fe-4S](2+) cluster, generating an ethyl-[4Fe-4S](3+) organometallic species termed Omega(E

52 p=0.029), five phthalate metabolites (mono-2-ethyl 5-carboxypentyl phthalate [p=0.016], mono-2-ethyl-

53 hat 2-{[2-(4-bromophenyl)-2-oxoethyl]thio}-3-ethyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4

54 Concentrations of mono-2-ethyl-5-carboxypentyl terephthalate, a metabolite of the

55 (2-ethylhexyl) terephthalate (DEHTP): mono(2-ethyl-5-carboxypentyl) terephthalate (MECPTP) more than

56 5-carboxypentyl phthalate [p=0.016], mono-2-ethyl-5-hydroxyhexyl phthalate [p=0.023], mono-2-ethyl-5

57 Using BKMR, we observed that mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) was the primary

58 xy-4-(1-methylpiperidin-4-yl)phenyl)amino)-7-ethyl-5-methyl-8-((4-methylthiophen-2-yl)methyl)-7,8-dih

59 l-5-hydroxyhexyl phthalate [p=0.023], mono-2-ethyl-5-oxohexyl phthalate [p=0.0085], mono-4-methyl-7-o

60 the PKA inhibitor N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide dihydrochloride but not

61 ase inhibitor H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide), and the responses un

62 he binding of BrMT analog 2-[2-({[3-(2-amino-ethyl)-6-bromo-1H-indol-2-yl]methoxy}k7methyl)-6-bromo-1

63 (4aR,5S,6R,8S,8aR)-5-(2-(Furan-3-yl)ethyl)-8-hydroxy-5,6,8a-trimethyl-3,4,4a,5,6,7,8,8a-octa

64 Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl est

65 romethane (DCM) as a diluent in concentrated ethyl acetate (EA)-based electrolyte, the co-solvent ele

66 and compare the biological activities of the ethyl acetate (EtOAc), methanolic (MeOH) and aqueous ext

67 evels of total phenols, sucrose, malic acid, ethyl acetate and 2-phenylethanol.

68 ules related to the VOO off-flavor (ethanol, ethyl acetate and acetic acid) was also shown.

69 Samples were extracted with ethyl acetate and cleaned up with primary secondary amin

70 extraction using different solvents (hexane, ethyl acetate and ethanol).

71 The reaction is carried out in ethyl acetate as a solvent.

72 d support, 20 mg activated charcoal and 5 mL ethyl acetate as elution solvent.

73 rtificial cerebral spinal fluid (aCSF) using ethyl acetate as the extraction phase.

74 Ethyl acetate can be defined a green and bio-based solve

75 gth, methanol content, acetaldehyde content, ethyl acetate content and higher alcohols content were e

76 y was higher in butanol extract, whereas the ethyl acetate extract had the highest inhibitory effect

77 nt and total flavonoid content were found in ethyl acetate extract, methanol extract possessed the st

78 ived lipid radicals were measured ex situ in ethyl acetate extracts of model systems and extrudates b

79 Interestingly, CFS and crude ethyl acetate extracts of PUFSTP35 (Bacillus licheniform

80 The ethyl acetate fraction inhibited in vitro alpha-glucosid

81 This study was designed to investigate ethyl acetate fraction of Chinese olive fruit extract (C

82 w/v), 80 min of shaking and by adding 30% of ethyl acetate in acetone, being beta-carotene the major

83 robic metabolites (acetaldehyde, ethanol and ethyl acetate), regardless of storage temperature and ti

84 , dodecane, nonanoic acid, 2-(2-butoxyethoxy)ethyl acetate, (E)-2-undecanal and (S)-germacrene D, wer

85 h water and ethanol prior to extraction with ethyl acetate, all MK-7 will be made accessible prior to

86 hylbutan-1-ol, 1-pentanol, octanal, nonanal, ethyl acetate, ethyl octanoate, and butane-2,3-dione) re

87 raction of the desired products using DCM or ethyl acetate, followed by subjecting the recovered aque

88 ropanoate, ethyl butanoate, ethyl octanoate, ethyl acetate, isoamyl acetate, isobutanol, 2-methyl-1-b

89 uated by measuring the (13)C polarization of ethyl acetate-1-(13)C, i.e., the product of pairwise add

90 lcohols, acetonitrile, acetone, toluene, and ethyl acetate.

91 emonstrated an increase in the production of ethyl acetate.

92 in water; B, ammonium hydroxide in water; C, ethyl acetate; D, methanol: water (1:1, v/v); and E, ace

93 with phenyl boronic acid (PBAc) followed by ethyl-acetate extraction.

94 crylate) (PSBMA), and poly(2-(methylsulfinyl)ethyl acrylate (PMSEA).

95 te) analogues of poly(methyl acrylate), poly(ethyl acrylate), and poly(butyl acrylate) is described.

96 alline blocks and acrylics (methyl acrylate, ethyl acrylate, n-butyl acrylate, and methyl methacrylat

97 and 16 steps, respectively, from butanal and ethyl acrylate.

98 to specific VOMs, as 3-methylbutanal (wort), ethyl alcohol and ethyl octanoate (fermentation, maturat

99 fermentation, maturation and filtration), or ethyl alcohol and isoamyl acetate (final product).

100 Determination of ethyl alcohol concentration was performed in 167 samples

101 Ethyl alcohol content in the beers manufactured ranged f

102 Ethyl alcohol contributes to its strong and pungent smel

103 Icosapent ethyl also reduced totals for each component of the prim

104 (2) (IrN 1, PNP = bis[2-diisopropylphosphino)ethyl]amide).

105 nolate ligand donor and two bis(2-{2-pyridyl}ethyl)amine arms), was generated from chemical oxidation

106 ere tren(py)(3) = tris(2-pyridyl-methylimino-ethyl)amine) and a series of benzoquinoid acceptors.

107 e ligand tris[2-(3-mesitylimidazol-2-ylidene)ethyl]amine (TIMEN(Mes)), which is known to support iron

108 3) (IrH 2, PNHP = bis[2-diisopropylphosphino)ethyl]amine) to IrN 1 proceeds through two successive hy

109 uorophenyl)(4-fluoro-4-(((2-(pyridin-2-yloxy)ethyl)amino)methyl)piperidin-1-yl)methanone (17, NLX-204

110 of 14 TM2 segment residues reacted with MTS-ethyl-ammonium-biotin (MTSEA-biotin).

111 )Bu-diamidoethane)(NEt(2)))(4)] (where Et is ethyl and (t)Bu is tert-butyl).

112 Methyl, ethyl and (Z)-3-hexenyl benzoate with 50% of the volatil

113 acetates (257 mg L(-1) to 547 mg L(-1)) and ethyl and methyl esters (183 mg L(-1) to 456 mg L(-1)) i

114 nging from 303 mg L(-1) to 905 mg L(-1)) and ethyl and methyl esters (ranging from 138 mg L(-1) to 41

115 elective 1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl-beta-d-ribofuranuronamide (NECA) and the selective

116 in a late-stage [4 + 1] condensation between ethyl bromoacetate and an enaminone possessing the remai

117 ilable compounds as 3-hydroxypropanenitrile, ethyl bromoacetate, and 2-acetyl butyrolactone, the synt

118 of the volatile compounds decreased, whilst ethyl butanoate remained constant.

119 istic compounds (hexanal, decanal, linalool, ethyl butanoate, alpha-pinene, beta-myrcene and (Z)-3-he

120 the wines for 3-mercaptohexanol, hexan-1-ol, ethyl butanoate, ethyl hexanoate, ethyl octanoate and ph

121 Ethyl propanoate, ethyl butanoate, ethyl octanoate, ethyl acetate, isoamyl

122 High OAVs were determined for ethyl butanoate, Z-3-hexenal, linalool and methyl benzoa

123 avioral and structural plasticity induced by ethyl butyrate (EB) or carbon dioxide (CO(2)) closes wit

124 ing just 3 odorants (ethyl 2-methylbutyrate, ethyl butyrate and hexanoate).

125 articles to a mixture of odorants, including ethyl butyrate, eugenol, and carvone, considerably incre

126 Pinoresinol, ethyl caffeate and ethyl gallate were detected for the f

127 , with ethyl isobutyrate, ethyl isovalerate, ethyl caproate, ethyl octanoate and ethyl decanoate as t

128 es mycotoxins, whilst the second encompasses ethyl carbamate, biogenic amines, sulfur dioxide and pro

129 Compound 1 (N-(N-(2-(1H-indol-3-yl)ethyl)carbamimidoyl)-2,5-difluorobenzenesulfonamide) and

130 (*)OH oxidizes 6:2 FTS by H-abstraction from ethyl carbons.

131 ASOs modified with high-affinity constrained Ethyl (cEt) nucleotides in the flanks.

132 containing modifications such as constrained ethyl (cEt), locked nucleic acid (LNA) and 2'-O-methoxye

133 derived FXR agonist obeticholic acid (OCA; 6-ethyl chenodeoxycholic acid) has shown promise in clinic

134 ion with the chiral agent (+)-1-(9-fluorenyl)ethyl chloroformate (FLEC), avoiding the use of referenc

135 ent-based non-toxic clearing (BALANCE) using ethyl cinnamate (ECi) with light sheet fluorescence micr

136 Accordingly, ethyl-coenzyme M (ethyl-CoM) was identified as an interm

137 haea that are able to oxidize ethane through ethyl-CoM are widespread members of the local communitie

138 . Argoarchaeum initiates ethane oxidation by ethyl-CoM formation, analogous to the recently described

139 Argoarchaeum initiates ethane oxidation by ethyl-CoM formation, analogous to the recently described

140 Accordingly, ethyl-coenzyme M (ethyl-CoM) was identified as an intermediate by liquid c

141 l variance), and the higher concentration of ethyl decanoate and ethyl octanoate, diethyl succinate,

142 alerate, ethyl caproate, ethyl octanoate and ethyl decanoate as the most abundant.

143 hylaminophenoxyethyl and 2-(1H-indol-4-yloxy)ethyl derivatives, respectively) were selected as biased

144 lladium carboxylate dimers, which polymerize ethyl diazoacetate, a carbene precursor in a controlled

145 ne intermediates from the photoexcitation of ethyl diazoacetoacetate.

146 Tryptophan ethyl ester concentration in all wines increased signifi

147 of the lactone ring by the formation of the ethyl ester derivative, the fluorophore absorbs at 920 n

148 ollowing cell transport, [1-(13)C]-l-alanine ethyl ester is instantaneously hydrolyzed to [1-(13)C]-l

149 cell viability assays revealed that 56, the ethyl ester of 53, was more potent than 53 in inhibiting

150 Alanine ethyl ester readily crosses cell membrane while simultan

151 serotonin, 3-indoleacetic acid, l-tryptophan ethyl ester) in commercial beers is reported for the fir

152 eled alanine derivative, [1-(13)C]-l-alanine ethyl ester, as a viable DNP probe whose chemical shift

153 hyl, a highly purified eicosapentaenoic acid ethyl ester, lowers triglyceride levels, but data are ne

154 and carboxyl group footprinting with glycine ethyl ester, were further applied to determine BsAb's bi

155 Enzymatic synthesis of fatty acid ethyl esters (FAEE) from chia (Salvia hispanica L.) oil

156 O(2) (16%) that could limit the synthesis of ethyl esters and gamma-butyrolactone, keeping the accumu

157 contents of some volatile compounds, such as ethyl esters and terpenes, as well as amino acids and ty

158 A mixture containing 14 ethyl esters at concentrations found in wine (V1) was pr

159 The detected ethyl esters can be suggested as markers to evaluate the

160 xepine-4-carboxylates with chiral amino acid ethyl esters for the first time.

161 ts ranging from 0.21 to 0.01 min(-1) for the ethyl esters from C(6) to C(19)).

162 Inter- and intraday precision of selected ethyl esters in aqueous solution was satisfactory (relat

163 ethod was validated for analysis of selected ethyl esters present in a yogurt drink.

164 EPA ethyl esters prevented obesity-induced glucose intoleran

165 Detection of fatty acid ethyl esters were confirmed in miso and found in homemad

166 profile of palinca were esters, particularly ethyl esters, with ethyl isobutyrate, ethyl isovalerate,

167 s and two acyl donors: ferulic acid (FA) and ethyl ferulate (EF).

168 Pinoresinol, ethyl caffeate and ethyl gallate were detected for the first time in these

169 ine follow-back method and monitored by hair ethyl glucuronide analysis.

170 k method, with abstinence confirmed by urine ethyl glucuronide testing.

171 Different activated aldehydes like ethyl glyoxalate and 2,2,2-trifluoroacetaldehyde also ef

172 Replacing the 1'-N-methyl with an ethyl group or adding a second 1'-N-methyl group signifi

173 ed in 17.2% of the patients in the icosapent ethyl group, as compared with 22.0% of the patients in t

174 rent specificities (k (cat)/K (M)): propyl > ethyl > methyl > guaiacol.

175 late anion on the catalytic cycle, whereas 2-ethyl hexanoate minimizes this inhibitory effect.

176 ercaptohexanol, hexan-1-ol, ethyl butanoate, ethyl hexanoate, ethyl octanoate and phenylethyl alcohol

177 milies (penta-2,3-dione, trans-2-hexen-1-al, ethyl hexanoate, nonan- and decan-2-one).

178 y using lipophilic bases such as potassium 2-ethyl hexanoate, the borylation reaction could be achiev

179 thalate, 16% mono-benzyl phthalate, 21% mono-ethyl hexyl phthalate, and 30% mono-isononyl phthalate),

180 ), such as dibutyl phthalate (DBP) and bis(2-ethyl hexyl) phthalate (DEHP), are now increasingly bein

181 ylene glycol, 5-hydroxymethyl-2-furaldehyde, ethyl hydrogen succinate, and 4-hydroxyphenethyl alcohol

182 comprise two key steps: (i) the formation of ethyl hydroperoxide (EHP) accompanying with the hydrogen

183 determine the degree of benefit of icosapent ethyl in the United States.

184 tion of Cardiovascular Events with Icosapent Ethyl - Intervention Trial) subgroup analysis was conduc

185 tion of Cardiovascular Events With Icosapent Ethyl-Intervention Trial [REDUCE-IT]; NCT01492361).

186 tion of Cardiovascular Events with Icosapent Ethyl-Intervention Trial) randomized 8,179 statin-treate

187 tion of Cardiovascular Events With Icosapent Ethyl-Intervention Trial) was a significant outlier and

188 tion of Cardiovascular Events with Icosapent Ethyl-Intervention Trial), a multicenter, double-blind,

189 To our knowledge, icosapent ethyl is the first non-low-density lipoprotein-lowering

190 higher content of octanoic acid, isobutanol, ethyl isoamyl succinate and catechin and a smaller amoun

191 were esters, particularly ethyl esters, with ethyl isobutyrate, ethyl isovalerate, ethyl caproate, et

192 Ru(NH(3))(5)(eina)](PF(6))(2), where eina is ethyl isonicotinate, anchored to anatase TiO(2) nanocrys

193 Chemical analysis revealed that ethyl isothiocyanate (EITC) and butyl isothiocyanate (BI

194 etaldehyde diethyl acetal, isobutyl acetate, ethyl isovalerate and guaiacol for CRE.

195 ularly ethyl esters, with ethyl isobutyrate, ethyl isovalerate, ethyl caproate, ethyl octanoate and e

196 hionol, capric acid, ethyl 2-methylbutyrate, ethyl isovalerate, ethyl monosuccionate, diethyl succina

197 Herein, we identified 1-(5-ethyl-isoxazol-3-yl)-3-(4-{2-[6-(4-ethylpiperazin-1-yl)p

198 form an intermediate alpha,beta-unsaturated ethyl ketone.

199 h phenylethyl alcohol, diethyl succinate and ethyl lactate having the highest flavor dilution factor.

200 lycal l-amicetal, synthesized de novo from l-ethyl lactate through tandem ring-closing metathesis-iso

201 Both IDL and ethyl linoleate/oleate downregulated inflammatory gene e

202 s of IDL in skin were compared with those of ethyl linoleate/oleate, which has previously been shown

203 protein 2 (VAMP2) is an essential soluble N-ethyl maleimide-sensitive factor attachment protein rece

204 entrations of menthol ("Menthol Arctic") and ethyl maltol ("No.

205 thol, triacetin, and cinnamaldehyde) to 80% (ethyl maltol) of the samples.

206 that were 30 times (menthol) and 100 times (ethyl maltol) their cytotoxic concentration.

207 fluids were effective in the MTT assay, and ethyl maltol, which was in over 50% of the products, was

208 copolymerization of anionic 2-(phosphonooxy)ethyl methacrylate (P) with non-ionic glycerol monometha

209 ning the same cationic poly(2-(dimethylamino)ethyl methacrylate) (D) block but placed in different ar

210 thylene glycol)-block-poly(2-(dimethylamino) ethyl methacrylate) (OD) readily encapsulate pDNA to for

211 butyl acrylate) (PBMA), poly(2-dimethylamino)ethyl methacrylate) (PDMAEMA) and poly(n-butyl acrylate-

212 and a hydrophilic poly[N,N-2-(dimethylamino)-ethyl methacrylate) block (PMMA-b-PDMAEMA), was synthesi

213 ethylmethacrylate) [PyBA-conj-AEMA] and 3-(1-ethyl methacryloylate)aniline to yield hetero-ladder ele

214 identified SAFEGUARD1 (SAFE1) in a screen of ethyl methanesulfonate (EMS) mutagenized flu ex1 plants

215 Here, we identified one ethyl methanesulfonate (EMS) mutant, deeply serrated (de

216 Two N. benthamiana ethyl methanesulfonate (EMS) mutants deficient for XopJ4

217 om a mutagenized oat population, produced by ethyl methanesulfonate mutagenesis, hulled grains from 1

218 results in rarity of such mutants, with the ethyl methanesulfonate-induced mutant ms5 among the few

219 t analysis of a previously identified tomato ethyl methanesulfonate-induced mutant that exhibits abno

220 hypersensitive to salt stress (hss) from an ethyl methanesulfonate-induced mutation population.

221 t with enhanced Cd tolerance, cadt1, from an ethyl methanesulphonate (EMS)-mutagenized population of

222 e sensor movement, via [2-(trimethylammonium)ethyl]methanethiosulfonate bromide (MTSET) modification

223 In an ethyl methyl carbonate-based battery electrolyte, 82 OP

224 we report the initial characterization of an ethyl methyl sulfonate-induced mutant population for the

225 With bulkier nucleophiles (ethyl/methyl cyanoacetate), the reaction proceeds with t

226 phosphorothioate (PS) ASOs with constrained-ethyl modifications (cEt).

227 1,2-Diphosphono-ethyl modifications were not tolerated.

228 he N,N-dimethyl-1,3,5-triazine-2,4-diamine-6-ethyl moiety by NMR spectroscopy, MALDI-TOF mass spectro

229 , ethyl 2-methylbutyrate, ethyl isovalerate, ethyl monosuccionate, diethyl succinate and gamma-butyro

230 s in human cells, where the alkyl groups are ethyl, n-butyl (nBu), and, for O (6)-alkyl-dG, pyridylox

231 Atrazine (6-Chloro-n-ethyl-n'-(1-methylethyl)-triazine-2,4-diamine), a preval

232 mice carrying homozygous and heterozygous N-ethyl-N-nitrosourea (ENU)-induced germline mutations for

233 In a forward genetic screen of N-ethyl-N-nitrosourea (ENU)-induced mutant mice for aberra

234 sociated with and stabilized GPR89, and an N-ethyl-N-nitrosourea (ENU)-induced mutation (explorer) in

235 throughout Oceania, and A20 I325N, from an N-ethyl-N-nitrosourea (ENU)-mutagenized mouse strain.

236 pes in Mecp2/Y mice after mutagenesis with N-ethyl-N-nitrosourea (ENU).

237 utline mouse mutagenesis with the chemical N-ethyl-N-nitrosourea and the strategy used to instantaneo

238 ains postnatally exposed to the carcinogen N-ethyl-N-nitrosourea developed PTMCs, which closely resem

239 Using N-ethyl-N-nitrosourea mutagenesis in mice in combination w

240 In a behavioral screen of N-ethyl-N-nitrosourea mutagenized mice we identified a mut

241 In a forward genetic screen of mice with N-ethyl-N-nitrosourea-induced mutations for defects in ada

242 s, where each was derived from an individual ethyl-nitrosurea mutagenized F(0) fish, two showed incre

243 eta-peptoids containing N-( S)-1-(1-naphthyl)ethyl ( Ns1npe) side chains can fold into unique triangu

244 as 3-methylbutanal (wort), ethyl alcohol and ethyl octanoate (fermentation, maturation and filtration

245 butyrate, ethyl isovalerate, ethyl caproate, ethyl octanoate and ethyl decanoate as the most abundant

246 exan-1-ol, ethyl butanoate, ethyl hexanoate, ethyl octanoate and phenylethyl alcohol.

247 1-pentanol, octanal, nonanal, ethyl acetate, ethyl octanoate, and butane-2,3-dione) representative of

248 higher concentration of ethyl decanoate and ethyl octanoate, diethyl succinate, hydroxylinalool, and

249 Ethyl propanoate, ethyl butanoate, ethyl octanoate, ethyl acetate, isoamyl acetate, isobuta

250 The key odorants were ethyl propionate, ethyl octanoate, propanoic acid and 4-ethylphenol for JR

251 lpha-beta-NiS composites using nickel alkyl (ethyl, octyl) xanthate precursors.

252 nyl)-N2-(2-(4-methyl-2-(p-tolyl)thiazol-5-yl)ethyl)oxalamide.

253 nd a C-terminal SnapTag domain react with an ethyl p-nitrophenyl phosphonate (pNPP) or a chloro-pyrim

254 8 were confirmed-including two alkylphenols, ethyl paraben, BPF, PFOSAA, benzophenone-3, benzyl p-hyd

255 ben biomarker concentrations (butyl paraben, ethyl paraben, methyl paraben [MP], and propyl paraben [

256 ciated with lower FEV(1)%: copper (p=0.041), ethyl-paraben (p=0.029), five phthalate metabolites (mon

257 ated by the TAAR1 agonist RO5166017 ((S)-4-[(ethyl-phenyl-amino)-methyl]-4,5-dihydro-oxazol-2-ylamine

258 methional/furfural for JPX, acetoin for MRE, ethyl phenylacetate and vanillin for MPX and acetaldehyd

259 rectly from random-sequence mixed P-methyl/P-ethyl phNA repertoires.

260 c, DNA-templated synthesis of P-methyl and P-ethyl phNAs, and the directed evolution of specific stre

261 ism of uranyl by poly(bis[2-(methacryloyloxy)ethyl] phosphate) (PB2MP) functionalised polyvinylidene

262 yacridin-9-yl)amino)-2-((4-(2-(dimethylamino)ethyl) piperazin-1-yl) methyl) phenol (compound 4), were

263 (3,4-difluorophenyl)-1H-pyrazol-3-yl)methoxy)ethyl)piperazin-1-yl)ethanone (9k, EST64454) as a sigma(

264 1-(4-(2-((bis(4-fluorophenyl)methyl)sulfinyl)ethyl)-piperazin-1-yl)-propan-2-ol (3b) was effective in

265 (4-(pyridin-2-yl)piperazin-1-yl)pyrazin-2-yl)ethyl)propanamide], are characterized as allosteric acti

266 Ethyl propanoate, ethyl butanoate, ethyl octanoate, ethy

267 (4-(pyridin-2-yl)piperazin-1-yl)pyrazin-2-yl)ethyl)propenamide (B-973B) showed reduced inward rectifi

268 n overall yield of 6% using myo-inositol and ethyl propiolate as the starting materials.

269 The key odorants were ethyl propionate, ethyl octanoate, propanoic acid and 4-

270 m (25 muL) spiked with a mixture of methyl-, ethyl-, propyl-, and butylparaben in a concentration ran

271 ntadentate ligand, 6-[6-(1,1-di-pyridin-2-yl-ethyl)-pyridin-2-ylmethyl]-[2,2']bipyridinyl (Py3Me-Bpy)

272 Since rodents, but not humans, can convert ethyl pyruvate to pyruvate in blood plasma, this additio

273 Its pharmacological precursor, ethyl pyruvate, has shown anti-inflammatory/anti-tissue

274 stituted 2-methylquinolines with diacetyl or ethyl pyruvate, under environmentally friendly condition

275 Upon annealing above 77K, the ethyl radical adds to the [4Fe-4S](2+) cluster, generati

276 Photolysis of SAE bound to HydG forms an ethyl radical trapped in the active site.

277 The ethyl radical withstands prolonged storage at 77 K and i

278 Icosapent ethyl reduced the need for first and subsequent coronary

279 ses determined the extent to which icosapent ethyl reduced total ischemic events.

280 Overall, icosapent ethyl reduced total primary endpoint events (61 vs. 89 p

281 on from ethyl 4-chloroacetoacetate (COBE) to ethyl (S)-4-chloro-3-hydroxybutanoate ((S)-CHBE) catalyz

282 hat a novel class of cationic alkyl ammonium ethyl side-chains demonstrates significant enforcement o

283 Icosapent ethyl significantly reduced percutaneous coronary interv

284 In time-to-first-event analyses, icosapent ethyl significantly reduced the risk of ischemic events,

285 the enantioselective construction of methyl-ethyl stereocentres, which is notoriously challenging in

286 -2'-(5-phenylacetamide-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) selected for a drug-resistant popu

287 2-[5-(phenylacetamido)-1,3,4-thiadiazol-2-yl]ethyl sulfide (BPTES), despite its poor physicochemical

288 s-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES), which curtails cells' glutamine c

289 tive for the photooxidation of 2-chloroethyl ethyl sulfide (CEES, a chemical warfare simulant of must

290 and terminating substrates, such as methyl, ethyl, tert-butyl acrylates, and substituted styrenes wi

291 SalL-catalyzed cofactor production with C-(m)ethyl transfer to coumarin substrates catalyzed by the m

292 o-treated patients versus 18.2% of icosapent ethyl-treated patients (hazard ratio [HR], 0.69 [95% CI,

293 )-mediated lactone aminolysis and a mild TBD/ethyl trifluoroacetate mediated lactam ring closure to a

294 er among those who received 2 g of icosapent ethyl twice daily than among those who received placebo.

295 ease higher contents of cis-3-hexen-1-ol and ethyl vanillate and affected yeast metabolism related to

296 and flavoring agents (for example vanillin, ethyl vanillin).

297 .2% (22.5/1000 patient-years) with icosapent ethyl versus 13.3% (33.7/1000 patient-years) with placeb

298 vs. 89 per 1,000 patient-years for icosapent ethyl versus placebo, respectively; rate ratio: 0.70; 95

299 44 per 1,000 patient-years for icosapent ethyl versus placebo, respectively; rate ratio: 0.72; 95

300 s, acrylates, acrylamide, acrylonitrile, and ethyl vinyl ketone in good yields.